New Frontiers in Subcutaneous Immunoglobulin Treatment

Subcutaneous immunoglobulin (SCIG) treatment provides stable serum immunoglobulin G (IgG) levels, is associated with fewer systemic adverse events than intravenous immunoglobulin (IVIG) treatment, and offers the convenience of home therapy. In clinical practice, IVIG is still used preferentially for...

Descripción completa

Detalles Bibliográficos
Autores principales: Jolles, Stephen, Stein, Mark R., Longhurst, Hilary J., Borte, Michael, Ritchie, Bruce, Sturzenegger, Matthias H., Berger, Melvin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare Communications 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873072/
https://www.ncbi.nlm.nih.gov/pubmed/24392293
http://dx.doi.org/10.1007/s13554-011-0009-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873072/
https://www.ncbi.nlm.nih.gov/pubmed/24392293
http://dx.doi.org/10.1007/s13554-011-0009-3

Ejemplares similares